Fosamax Plus D » FDA & Pescription Drugs Lawyer New York
Call For A FREE Consultation!
1 (800) 509-2335
You are here: FDA says Osteoporosis Drug Labels Must Warn Patients of Risk of Leg Fractures
 
Monthly Archives
Recent Entries
Archives by Tag 'Fosamax Plus D'

FDA says Osteoporosis Drug Labels Must Warn Patients of Risk of Leg Fractures

By Marc J. Bern - Last updated: Wednesday, October 13, 2010

The U.S. Food and Drug Administration (FDA) announced today that the agency is requiring the labels of bisphosphonate osteoporosis drugs Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia and Reclast (and their generic products) to include a warning about increased risk of fracture of the thigh bone. Doctors prescribe these bisphosphonates for the [...]

Terms of Use and Privacy Policy | Disclaimer
1 (800) 509-2335
Attorney Advertising: Prior results do not guarantee a similar outcome. This website is for informational purposes only, does not constitute legal advice and may not reflect the most current legal developments. Use of this website does not create an attorney-client relationship, only a written contract between the parties can establish an attorney-client relationship. Napoli Bern Ripka LLP and all contributing authors expressly disclaim all liability to any person with respect to the contents of this website. Imagery used on this website utilizes fictionalized events or scenes with participation of models. For complete details, read our Terms of Use and Privacy Policy.
Locations